Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Motrin Oral Suspension, 100 mg/5 mL, of McNeil Consumer Healthcare (McNeil)
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
New block enhances the company's global capabilities in Oral Solid Dosage (OSD) Forms, increasing total plant capacity to 4.5 billion doses
Pfizer calls upon global health leaders and organizations to join the Accord, bringing their expertise and resources to close the health equity gap
The key categories include intimate wellness, skincare & hair care
Subscribe To Our Newsletter & Stay Updated
